Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy by slowing glucosphingolipid synthesis.

N S Radin1

  • 1Department of Psychiatry, The University of Michigan Medical School, Ann Arbor, USA. Glyconorm@aol.com

Biochemical Pharmacology
|February 26, 1999
PubMed
Summary

Inhibiting glucosphingolipid (GSL) synthesis offers a novel therapeutic strategy for numerous diseases. Slowing GSL production may treat Gaucher

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infections and glycolipids.

Postgraduate medical journal·2003
Same author

Apoptotic death by ceramide: will the real killer please stand up?

Medical hypotheses·2001
Same author

Treating glucosphingolipid disorders by chemotherapy: use of approved drugs and over-the-counter remedies.

Journal of inherited metabolic disease·2001
Same author

Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?

European journal of biochemistry·2001
Same author

Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells.

British journal of cancer·1999
Same author

Effect of an inhibitor of glucosylceramide synthesis on cultured human keratinocytes.

The Journal of dermatology·1998

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Oncology
  • Infectious Diseases

Background:

  • Glucosphingolipids (GSLs) play crucial roles in cellular processes.
  • Aberrant GSL metabolism is implicated in various pathological conditions.
  • Current treatments often address symptoms rather than underlying GSL dysregulation.

Purpose of the Study:

  • To propose and explore the therapeutic potential of inhibiting GSL synthesis.
  • To investigate GSL synthesis inhibition as a unified treatment approach for diverse diseases.
  • To highlight the role of GSLs in cancer, diabetes, and infectious diseases.

Main Methods:

  • Hypothesizing the efficacy of GSL synthesis inhibitors.
  • Reviewing existing literature on GSLs in disease pathogenesis.
  • Proposing therapeutic strategies based on modulating GSL synthesis rates.

Main Results:

  • Inhibiting GSL synthesis could manage GSL accumulation in lysosomal storage diseases like Gaucher's disease.
  • Blocking tumor GSL production may enhance anti-tumor immunity and overcome multidrug resistance.
  • GSL synthesis inhibition may prevent diabetic nephropathy and combat GSL-mediated infections.

Conclusions:

  • Targeting GSL synthesis presents a promising, broadly applicable therapeutic avenue.
  • Pharmacological inhibition of GSL synthesis warrants further investigation across multiple disease areas.
  • Modulating GSL metabolism offers a potential strategy to restore cellular homeostasis and treat disease.

Related Experiment Videos